These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21442172)

  • 21. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.
    Lee SS; Chou KJ; Dou HY; Huang TS; Ni YY; Fang HC; Tsai HC; Sy CL; Chen JK; Wu KS; Wang YH; Lin HH; Chen YS
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1451-7. PubMed ID: 20538837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.
    Fuchs I; Avnon L; Freud T; Abu-Shakra M
    Clin Rheumatol; 2009 Feb; 28(2):167-72. PubMed ID: 18795393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
    Nobre CA; Callado MR; Lima JR; Gomes KW; Martiniano GV; Vieira WP
    Rheumatol Int; 2012 Sep; 32(9):2769-75. PubMed ID: 21822912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.
    Shovman O; Anouk M; Vinnitsky N; Arad U; Paran D; Litinsky I; Caspi D; Elkayam O
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1427-32. PubMed ID: 19861018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
    Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
    Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
    Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
    Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
    Keystone EC; Papp KA; Wobeser W
    J Rheumatol; 2011 Jul; 38(7):1234-43. PubMed ID: 21459944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interplay of Disease Modifying Anti Rheumatic Drugs and Tuberculin Skin Test.
    Abdullah Z; Kumar A; Khan MA; Kumar U; Vyas S; Vishwakarma VK; Ranjan P; Biswas A; Wig N
    Curr Rev Clin Exp Pharmacol; 2021; 16(4):350-356. PubMed ID: 33390147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti-TNF agents for rheumatologic diseases.
    Kilinc AA; Onal P; Oztosun B; Yildiz M; Adrovic A; Sahin S; Barut K; Cokugras H; Kasapcopur O
    Pediatr Pulmonol; 2020 Oct; 55(10):2689-2696. PubMed ID: 32776324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population.
    Kim EY; Lim JE; Jung JY; Son JY; Lee KJ; Yoon YW; Park BH; Moon JW; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    BMC Infect Dis; 2009 Dec; 9():207. PubMed ID: 20003535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.
    Jung SM; Ju JH; Park MS; Kwok SK; Park KS; Kim HY; Yim HW; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):323-30. PubMed ID: 25557144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy.
    Lioté H; Lioté F
    Joint Bone Spine; 2011 Jul; 78(4):352-7. PubMed ID: 21251863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
    Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis.
    Song GG; Bae SC; Lee YH
    Int J Rheum Dis; 2013 Jun; 16(3):279-83. PubMed ID: 23981748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.